OTC - ACTIVE INGREDIENT SECTION
Arbutin 0.4%
Glutathione 0.1%
Niacinamide 0.1%
Arbutin 0.4%
Glutathione 0.1%
Niacinamide 0.1%
Water
Cyclopentasiloxane
Dimethicone
Glycerin
Diethylhexyl Carbonate
Titanium Dioxide
Butylene Glycol
C12-15 Alkyl Benzoate
Polymethylsilsesquioxane
Citric acid
Polyglyceryl-4Diisostearate/
Polyhydroxystearate/Sebacate
Ethylhexyl Methoxycinnamate
Cetyl PEG/PPG-10/1 Dimethicone
Imidazolidinyl Urea
Benzophenone-3
Cetearyl Dimethicone Crosspolymer
Sodium Chloride
Hydrolyzed Extensin
Phospholipids
Parfum
Phenoxyethanol
Betaine
Collagen
Apply over your body daily
in the morning andbefore bed.
Apply over your body daily in the morning and before bed.
Moisturizing
For external use only.
Stop use and ask a doctor if rash occurs.
When using this product keep out of eyes. Rinse with water to remove.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 74458-020-01 | 2026-01-29 | C162847 | 48780-1 | 49896155-a0f2-586f-e063-e6dba90add90 | GZE AHA Body Lotion |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 74458-020-01 | GZE AHA BodyLotion | 40 g in 1 TUBE | CREAM | 40 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 74458-020 | 74458-020-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 27f382f5-4d89-c699-e063-6294a90a1c22 | 27f382f5-4d88-c699-e063-6294a90a1c22 | 2024-11-28 | Warnings | 27f382f5-4d89-c699-e063-6294a90a1c22 27f382f5-4d88-c699-e063-6294a90a1c22 |
Adverse event summaries are temporarily unavailable. Other product information remains available.